Both Sys1 and Sygdh, two codon-optimized genes encoding SyS1 and SyGDH, were synthesized based on the carbonyl reductase (S1) and glucose 1-dehydrogenase (GDH) gene sequences, respectively, from Candida magnoliae and Thermoplasma acidophilum, and co-expressed in Escherichia coli BL21(DE3) using two strategies. One strategy involved a recombinant E. coli strain (E. coli/Sygdh-Sys1) constructed by transforming a recombinant plasmid, pETDuet-Sygdh-Sys1, into E. coli BL21. The other strategy involved another recombinant E. coli strain (E. coli/Sys1/ Sygdh) obtained by co-transforming the recombinant plasmids pET-22b-Sys1 and pET-28a-Sygdh into E. coli BL21. The enzyme activity assays indicated that the activities of recombinant SyS1 and SyGDH (3.7 and 56.3 U/g wet cells) expressed in E. coli/Sygdh-Sys1 were higher than those (2.8 and 44.1 U/g wet cells) in E. coli/Sys1/Sygdh. Accordingly, E. coli/Sygdh-Sys1 was chosen, and its whole cells were used as catalysts for the asymmetric reduction of m-chlorophenacyl chloride (m-CPC) to the corresponding (R)-2-chloro-1-(3-chlorophenyl)ethanol [(R)-CCE] coupled with the regeneration of NADPH in situ. Under the optimized reaction conditions of 30 mM m-CPC, 50 mg/ml wet cells, 40 mM glucose and 0.2 mM NADP + at pH 7.0 and 35°C for 3 h, (R)-CCE was obtained with a molar yield of 99.2 % and an enantiomeric excess (e.e.) value of more than 99 %.